Abstract
Objectives: Dipyridamole stress cardiac magnetic resonance (CMR) evaluates the key phases (perfusion and wall motion) of the ischemic cascade. We sought to determine the prognostic value of dipyridamole stress-CMR in consecutive patients symptomatic for chest pain. Methods: Seven hundred and ninety-three consecutive patients symptomatic for chest pain underwent dipyridamole stress-CMR and were followed up for 810 ± 665 days. Patients were classified in group 1 (no- reversible ischemia), group 2 (stress perfusion defect alone), and group 3 [stress perfusion defect plus abnormal wall motion (AWM)]. End points were "all cardiac events" (myocardial infarction, cardiac death and revascularization) and "hard cardiac events" (all cardiac events excluding revascularization). Results: One hundred and ninety-five (24 %) all cardiac events and 53 (7 %) hard cardiac events were observed. All and hard cardiac event rates in groups 1, 2, and 3 were 11 %, 49 %, 69 % and 4 %, 8 %, 21 %, respectively, with a higher rate in group 2 vs. group 1 (p
| Original language | English |
|---|---|
| Journal | European Radiology |
| DOIs | |
| Publication status | Accepted/In press - Oct 29 2015 |
Fingerprint
Keywords
- Coronary artery disease
- Magnetic resonance
- Myocardial ischemia
- Myocardial perfusion imaging
- Prognosis
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Cite this
Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease : a mid-term follow-up study. / Pontone, Gianluca; Andreini, Daniele; Bertella, Erika; Loguercio, Monica; Guglielmo, Marco; Baggiano, Andrea; Aquaro, Giovanni Donato; Mushtaq, Saima; Salerni, Sara; Gripari, Paola; Rossi, Carmen; Segurini, Chiara; Conte, Edoardo; Beltrama, Virginia; Giovannardi, Marta; Veglia, Fabrizio; Guaricci, Andrea Igoren; Bartorelli, Antonio L.; Agostoni, Piergiuseppe; Pepi, Mauro; Masci, Pier Giorgio.
In: European Radiology, 29.10.2015.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease
T2 - a mid-term follow-up study
AU - Pontone, Gianluca
AU - Andreini, Daniele
AU - Bertella, Erika
AU - Loguercio, Monica
AU - Guglielmo, Marco
AU - Baggiano, Andrea
AU - Aquaro, Giovanni Donato
AU - Mushtaq, Saima
AU - Salerni, Sara
AU - Gripari, Paola
AU - Rossi, Carmen
AU - Segurini, Chiara
AU - Conte, Edoardo
AU - Beltrama, Virginia
AU - Giovannardi, Marta
AU - Veglia, Fabrizio
AU - Guaricci, Andrea Igoren
AU - Bartorelli, Antonio L.
AU - Agostoni, Piergiuseppe
AU - Pepi, Mauro
AU - Masci, Pier Giorgio
PY - 2015/10/29
Y1 - 2015/10/29
N2 - Objectives: Dipyridamole stress cardiac magnetic resonance (CMR) evaluates the key phases (perfusion and wall motion) of the ischemic cascade. We sought to determine the prognostic value of dipyridamole stress-CMR in consecutive patients symptomatic for chest pain. Methods: Seven hundred and ninety-three consecutive patients symptomatic for chest pain underwent dipyridamole stress-CMR and were followed up for 810 ± 665 days. Patients were classified in group 1 (no- reversible ischemia), group 2 (stress perfusion defect alone), and group 3 [stress perfusion defect plus abnormal wall motion (AWM)]. End points were "all cardiac events" (myocardial infarction, cardiac death and revascularization) and "hard cardiac events" (all cardiac events excluding revascularization). Results: One hundred and ninety-five (24 %) all cardiac events and 53 (7 %) hard cardiac events were observed. All and hard cardiac event rates in groups 1, 2, and 3 were 11 %, 49 %, 69 % and 4 %, 8 %, 21 %, respectively, with a higher rate in group 2 vs. group 1 (p
AB - Objectives: Dipyridamole stress cardiac magnetic resonance (CMR) evaluates the key phases (perfusion and wall motion) of the ischemic cascade. We sought to determine the prognostic value of dipyridamole stress-CMR in consecutive patients symptomatic for chest pain. Methods: Seven hundred and ninety-three consecutive patients symptomatic for chest pain underwent dipyridamole stress-CMR and were followed up for 810 ± 665 days. Patients were classified in group 1 (no- reversible ischemia), group 2 (stress perfusion defect alone), and group 3 [stress perfusion defect plus abnormal wall motion (AWM)]. End points were "all cardiac events" (myocardial infarction, cardiac death and revascularization) and "hard cardiac events" (all cardiac events excluding revascularization). Results: One hundred and ninety-five (24 %) all cardiac events and 53 (7 %) hard cardiac events were observed. All and hard cardiac event rates in groups 1, 2, and 3 were 11 %, 49 %, 69 % and 4 %, 8 %, 21 %, respectively, with a higher rate in group 2 vs. group 1 (p
KW - Coronary artery disease
KW - Magnetic resonance
KW - Myocardial ischemia
KW - Myocardial perfusion imaging
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=84945579114&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84945579114&partnerID=8YFLogxK
U2 - 10.1007/s00330-015-4064-x
DO - 10.1007/s00330-015-4064-x
M3 - Article
AN - SCOPUS:84945579114
JO - European Radiology
JF - European Radiology
SN - 0938-7994
ER -